AI-generated summary
The authors used cultured immune cells from persons with multiple sclerosis and healthy donors and exposed them to red or near-infrared light. They report that light modulated interferon gamma and interleukin-10 production in a dose- and wavelength-dependent way, with responses differing between groups. The authors note that direct treatment of patients should be approached with extreme caution because of the risk of immune imbalance.
- Who or what was studied
- Persons with multiple sclerosis and healthy donors; peripheral blood mononuclear cells and CD4+ T cells isolated for in vitro culture
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study is an in vitro cell culture experiment, so its findings may not translate directly to patients, and the abstract does not state the number of donors.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.